Decreased LDLR activity could be a contributing factor since increased hepatic apoB production has also been observed in FH patients with LDLR mutations (Cummings et al., 1995; Tremblay et al., 2004; Millar et al., 2005). This evidence concerns the gene APOB and familial hyperaldosteronism.